BIOTW

Biotech Acquisition Company Warrant
BIOTW

Delisted

BIOTW was delisted on the 2nd of February, 2023.

51 hedge funds and large institutions have $3.8M invested in Biotech Acquisition Company Warrant in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+3
Holders Change %
+6.25%
% of All Funds
0.88%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
5
Closed
Calls
$5.72M
Puts
Net Calls
+$5.72M
Net Calls Change
+$4K
Name Holding Trade Value Shares
Change
Shares
Change %
RCM
1
Radcliffe Capital Management
Pennsylvania
$2.01M
BFM
2
Boothbay Fund Management
New York
$633K -$248K -25,043 -28%
LP
3
LMR Partners
United Kingdom
$496K
SCM
4
Segantii Capital Management
Hong Kong
$248K
HIM
5
HGC Investment Management
Ontario, Canada
$73K -$73.9K -1,228,782 -50%
PAMP
6
Polar Asset Management Partners
Ontario, Canada
$37K
RA
7
Ramius Advisors
New York
$34K
AC
8
Aristeia Capital
Connecticut
$34K
CCP
9
Corbin Capital Partners
New York
$28K
KCM
10
Kingstown Capital Management
New York
$18K
ACM
11
Atalaya Capital Management
New York
$17K
QGA
12
Q Global Advisors
Texas
$15K
LA
13
Linden Advisors
New York
$14K
SCM
14
Shaolin Capital Management
Florida
$12K
TI
15
Telemetry Investments
New York
$9K
MI
16
MMCAP International
Cayman Islands
$8K
TCM
17
Tenor Capital Management
New York
$8K
SC
18
Sculptor Capital
New York
$8K
RCM
19
Rivernorth Capital Management
Florida
$7K
AC
20
Antara Capital
New York
$7K
CH
21
CVI Holdings
Delaware
$6K
ACA
22
Arena Capital Advisors
California
$6K
PC
23
Periscope Capital
Ontario, Canada
$6K +$6K +100,000 New
DKCM
24
Davidson Kempner Capital Management
New York
$5K
Citadel Advisors
25
Citadel Advisors
Florida
$4K -$79 -1,408 -2%